21 – 30 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Clinical Impact of 2-Deoxy-2-[18F]fluoro-D-Glucose (FDG)-Positron Emission Tomography (PET) on Treatment Choice in Recurrent Cancer of the Cervix Uteri.
(
- Contribution to journal › Article
- 2011
-
Mark
Central nervous system metastases from epithelial ovarian cancer : Prognostic factors and outcome
(
- Contribution to journal › Article
- 2010
-
Mark
Adjuvant chemotherapy in endometrial cancer.
(
- Contribution to journal › Article
- 2009
-
Mark
Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells.
(
- Contribution to journal › Article
-
Mark
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Response to letter of Escobar et al.
(
- Contribution to journal › Article
-
Mark
Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - long-term follow-up
(
- Contribution to journal › Article
- 2007
-
Mark
Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40.
(
- Contribution to journal › Article
-
Mark
Transvaginal ultrasound and lactate dehydrogenase isoenzyme activity profile in uterine aspirate for diagnosis of endometrial carcinoma in women with postmenopausal bleeding.
(
- Contribution to journal › Article
- 2006
-
Mark
Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma.
(
- Contribution to journal › Article